NCT02343224View on ClinicalTrials.gov

Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

November 11, 2020

Study Completion Date

November 11, 2020

Conditions
Juvenile Pilocytic AstrocytomasOptic Pathway Gliomas
Interventions
DRUG

Pegylated interferon alpha-2b

PEG-Intron 1mcg/kg/dose weekly through an injection under the skin on the same day each week

Trial Locations (1)

30322

Children's Healthcare of Atlanta, Atlanta

All Listed Sponsors
collaborator

CURE Childhood Cancer, Inc.

OTHER

lead

Emory University

OTHER

NCT02343224 - Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas | Biotech Hunter | Biotech Hunter